A. Gene products not detected, or below 5Â pg/ml, in BAL fluid | |
 Gene products | IFNG, IL2, IL3, IL4, IL5, IL10, IL12 (p70), IL13, IL17, CXCL9 |
Gene product | PBS | 3Â h post-LPS | 24Â h post-LPS | ||
---|---|---|---|---|---|
wt | wt | Rgs2 − /− | wt | Rgs2 − /− | |
B. Gene products showing low expression (< 100 pg/ml) in the BAL fluid following LPS exposure | |||||
 CCL2 (MCP-1) | 7.9 ± 1.4 | 10.9 ± 1.7 | 11.3 ± 4.1 | 6.6 ± 1.1 | 5.3 ± 0.8 |
 CCL5 (RANTES) | 4.6 ± 0.6 | 10.1*** ± 0.9 | 8.8 ± 0.7 | 5.7 ± 0.3 | 5.1 ± 0.5 |
 CCL11 (Eotaxin) | 2.5 ± 0.3 | 10.2*** ± 1.6 | 10.7 ± 1.2 | 4.3 ± 1.1 | 4.8 ± 0.98 |
 CSF1 (MCSF) | 13.4 ± 9.5 | 5.9 ± 4.4 | 4.9 ± 3.1 | 1.4 ± 0.1 | 1.5 ± 0.2 |
 CXCL5 (LIX) | 38.6 ± 21.7 | 32.5 ± 17.9 | 79.2 ± 45.2 | 10.5 ± 7.4 | 10.7 ± 7.4 |
 CXCL10 (IP10) | 1.9 ± 0.3 | 59.9*** ± 12.9 | 45.5 ± 5.5 | 6.6 ± 1.3 | 5.0 ± 1.2 |
 IL1A | 20.4 ± 5.1 | 30.4 ± 4.4 | 30.1 ± 2.5 | 17.9 ± 2.8 | 24.4 ± 4.2 |
 IL1B | 2.0 ± 0.4 | 6.0 ± 1.5 | 8.3 ± 1.3 | 2.6 ± 0.6 | 2.6 ± 0.5 |
 IL7 | 4.9 ± 1.2 | 5.4 ± 0.4 | 6.8 ± 0.7 | 3.9 ± 0.4 | 4.8 ± 0.2 |
 IL9 | 14.9 ± 5.8 | 12.1 ± 1.4 | 13.4 ± 1.5 | 18.2 ± 3.8 | 22.5 ± 4.1 |
 IL12B (IL12 p40) | 4.0 ± 1.0 | 8.6 ± 1.5 | 13.47# ± 1.6 | 5.4 ± 0.7 | 12.79### ± 2.5 |
 IL15 | 3.5 ± 0.6 | 6.4 ± 1.2 | 5.2 ± 1.1 | 2.7 ± 0.5 | 2.5 ± 0.5 |
 LIF | 0.7 ± 0.1 | 15.4** ± 1.7 | 19.0 ± 1.1 | 0.9 ± 0.1 | 0.9 ± 0.1 |
 VEGF | 8.0 ± 1.8 | 8.0 ± 2.3 | 8.3 ± 0.7 | 11.0 ± 3.1 | 11.0 ± 1.6 |